Effect of Preoperative Curcumin in Breast Cancer Patients

Effect of Preoperative Curcumin in Breast Cancer Patients

Effect of curcumin on modulation of immune and inflammatory parameters in pre-operative patients

Patients diagnosed with breast cancer will be supplemented with either curcumin or placebo for a minimum period of 2 weeks and may be extended up to 4 weeks prior to their surgery.

Inclusion Criteria:

• Patients with operable breast cancer
• Life expectancy of at least 3 months
• Adequate organ function
• No allergy to curcumin
• Provides consent to participate in trial and adhere to the study protocol

Exclusion Criteria:

• Receiving concomitant radiotherapy, hormonal, immune therapy or other investigational drugs
• Uncontrolled concurrent illness
• Patient of anti platelet medications
• Pregnant / breast feeding
• Patients who are unable or unwilling to take curcumin, herbal remedies, or non-prescription medications
• Patients with bleeding tendency, bleeding disorders and abnormal bleeding/clotting profile